STUDY OF THE DNA DAMAGE IN HeLa CELLS EXPOSED TO THE COMBINATION OF ULTRASOUND AND 5-FLUORURACYL

Author:

Frantsiyants E. M.1ORCID,Surikova E. I.1ORCID,Goroshinskaya I. A.1ORCID,Moiseenko T. I.1ORCID,Nazaralieva N. A.1,Potemkin D. S.1ORCID,Vasilchenko N. G.1

Affiliation:

1. Rostov Research Institute of Oncology of the Ministry of Health of Russia

Abstract

To understand the mechanism of the effect of 5 % 5-fluorouracil (5-FU) gel used simultaneously with ultrasound (US ) on a tumor in patients with cervical cancer, the level of DNA damage was studied in vitro. We used cervical adenocarcinoma HeLa CC L-2 cells cultured under standard conditions in RPMI-1640 medium with 10 % fetal bovine serum and 50 μg / ml gentamicin. Ultrasound exposure lasted 10 min. (frequency of 0.88 MHz and intensity of 0.2 W / cm2). The 5-FU dose was 0.7 мкМ, with the time of exposure of 24 hours. In 24 hours after starting exposure, the level of DNA damage to the cells of the culture was studied using the comet assay in the alkaline version and evaluated by the % DNA parameter in the comet tail (% TDNA). The statistical significance of the differences was evaluated using the Mann-Whitney U test and Fisher’s exact test. The combined exposure to ultrasound / 5-FU led to a 5.2-fold increase in % TDNA compared to the control culture, % TDNA was 1.9 times higher after exposure to 5-FU alone and 3.0 times higher after exposure to ultrasound alone. In 24 hours after the combined exposure, less than 50 % of the culture cells had a low level of DNA damage (<10 % TDNA), i.e. completed the repair process and could continue to proliferate, and more than 30 % of the culture cells still had a high level of damage (>30 % TDNA) and were probably in the process of apoptosis. Thus, the results of the study showed that the combined effect of ultrasound / 5-FU on the HeLa culture helped to overcome resistance to chemotherapy, having a synergistic effect.

Publisher

Tomsk Cancer Research Institute

Subject

Cancer Research,Oncology

Reference17 articles.

1. Merabishvili V.M., Bakhidze E.V., Laliantsy E.I., Urmancheeva A.F., Krasilnikov I.A., Atroshchenko A.V. Prevalence of gynecological cancer and survival of patients. Problems in Oncology. 2014; 60(3): 288–297. (in Russian).

2. Kit O.I., Frantsiyants E.M., Men’shenina A.P., Moiseenko T.I., Ushakova N.D., Popova N.N., Yakushin A.V. Role of plasmapheresis and xenon therapy in correcting the acute effects of surgical menopause in patients with cervical cancer. Scientific Journal of Kuban State Agrarian University. 2016; 117(03). URL: http://ej.kubagro.ru/2016/03/pdf/29.pdf. (дата обращения: 24.01.2019). (in Russian).

3. Aksel E.M., Vinogradova N.N. Statistics of malignant neoplasms of female reproductive organs. Oncogenecology. 2018; 27(3): 64–78. (in Russian).

4. Menshenina A.P., Moiseenko T.I., Ushakova N.D. Possibilities for optimizing preoperative polychemotherapy in patients with invasive cervical cancer. Malignant tumors. 2014; (3): 30–36. (in Russian)]. doi: 10.18027/2224-5057-2014-3-30-36.

5. Menshenina A.P., Moiseenko T.I., Frantsiyants E.M., Ushakova N.D., Nazaralieva N.A. Comparative assessment of various modifications preoperative polychemotherapy in patients with locally advanced cervical cancer. Fundamental research. 2015; (1–8): 1629–1633. (in Russian).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3